PepGen Reports First Quarter 2022 Financial Results and Rece

16.06.2022 - BOSTON, June 16, 2022 (GLOBE NEWSWIRE) - PepGen Inc. (“PepGen”), a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapies with the goal of transforming the treatment of severe neuromuscular and neurological ...

Related Keywords

Canada , Laurence Watts , Gwendolyn Schanker , Jeffrey Foy , Head Of Clinical Development , Lifesci Communications , Gilmartin Group , Drug Administration , Health Canada , Pepgen Inc , Recent Corporate , Clinical Trial Application , Laurie Keating , Michelle Mellion , Senior Vice President , Jennifer Cormier , Clinical Operations , Vice President , Pipeline Assets , Three Months Ended March , Enhanced Delivery Oligonucleotide , Private Securities Litigation Reform Act , Consolidated Statements ,